Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI)
NCT04568616
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
178
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
ER Positive Breast Cancer
Interventions
DRUG:
Letrozole 2.5mg
Sponsor
Dartmouth-Hitchcock Medical Center